These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3134699)

  • 1. Procainamide-induced lupus anticoagulant.
    Heyman MR; Flores RH; Edelman BB; Carliner NH
    South Med J; 1988 Jul; 81(7):934-6. PubMed ID: 3134699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procainamide-induced lupus anticoagulants and thrombosis.
    Li GC; Greenberg CS; Currie MS
    South Med J; 1988 Feb; 81(2):262-4. PubMed ID: 3124275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombosis associated with procainamide-induced lupus anticoagulant.
    List AF; Doll DC
    Acta Haematol; 1989; 82(1):50-2. PubMed ID: 2505475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procainamide induced lupus anticoagulant.
    Weber MT; Hocking WG
    Wis Med J; 1988 Sep; 87(9):30-2. PubMed ID: 3142154
    [No Abstract]   [Full Text] [Related]  

  • 5. Pulmonary thromboembolism associated with procainamide induced lupus syndrome and anticardiolipin antibodies.
    Asherson RA; Zulman J; Hughes GR
    Ann Rheum Dis; 1989 Mar; 48(3):232-5. PubMed ID: 2494958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lupus anticoagulants in children.
    Singh AK; Rao KP; Kizer J; Lazarchick J
    Ann Clin Lab Sci; 1988; 18(5):384-7. PubMed ID: 3140708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level.
    Petri M; Rheinschmidt M; Whiting-O'Keefe Q; Hellmann D; Corash L
    Ann Intern Med; 1987 Apr; 106(4):524-31. PubMed ID: 3103510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times.
    Alving BM; Barr CF; Tang DB
    Am J Med; 1990 Feb; 88(2):112-6. PubMed ID: 2105643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procainamide-induced circulating anticoagulants in a congenitally-deficient factor XI patient.
    Clyne LP; Farber LR; Chopyk RL
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(2):239-44. PubMed ID: 2475403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ["Lupus anticoagulant" in immune hyperthyroidism].
    Schuler G; Alexopoulos A; Hasler K; Kerp L
    Dtsch Med Wochenschr; 1990 Oct; 115(40):1511-4. PubMed ID: 2120025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superficial migratory thrombophlebitis and the lupus anticoagulant.
    Blum F; Gilkeson G; Greenberg C; Murray J
    Int J Dermatol; 1990 Apr; 29(3):190-2. PubMed ID: 2110553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interference with anticoagulation monitoring by procainamide-induced lupus anticoagulant.
    Metzdorff MT; Hanses KS; Wright GL; Fried SJ
    Ann Thorac Surg; 1996 Mar; 61(3):994-5. PubMed ID: 8619736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on a circulating anticoagulant in procainamide-induced lupus erythematosus.
    Edwards RL; Rick ME; Wakem CJ
    Arch Intern Med; 1981 Nov; 141(12):1688-90. PubMed ID: 6171218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lupus anticoagulant and its role in thrombosis.
    Tobelem G; Cariou R; Camez A
    Blood Rev; 1987 Mar; 1(1):21-4. PubMed ID: 3139112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The laboratory heterogeneity of lupus anticoagulants.
    Triplett DA; Brandt JT; Maas RL
    Arch Pathol Lab Med; 1985 Oct; 109(10):946-51. PubMed ID: 3929747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of various screening and confirmatory tests for the detection of the lupus anticoagulant.
    Forastiero RR; Falcón CR; Carreras LO
    Haemostasis; 1990; 20(4):208-14. PubMed ID: 2122955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating inhibitors of blood coagulation associated with procainamide-induced lupus erythematosus.
    Davis S; Furie BC; Griffin JH; Furie B; Willey R
    Am J Hematol; 1978; 4(4):401-7. PubMed ID: 717399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case report: the lupus anticoagulant-hypoprothrombinemia syndrome.
    Peacock NW; Levine SP
    Am J Med Sci; 1994 May; 307(5):346-9. PubMed ID: 8172228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for thrombosis in lupus patients.
    Hasselaar P; Derksen RH; Blokzijl L; Hessing M; Nieuwenhuis HK; Bouma BN; De Groot PG
    Ann Rheum Dis; 1989 Nov; 48(11):933-40. PubMed ID: 2512863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.